contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


raysearch-laboratories-interim-report-april-june-2024

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

RaySearch Laboratories is a biotechnology company. The company specializes in the development of software solutions for the healthcare industry. An area where the company's products are used is in the treatment of cancer and other serious diseases. The company's products include products for dose planning and information systems. Various features include machine learning, computational speed, automated planning, virtual simulation, adaptive therapy, and digital workflows. The products are used by several clinics around the global market.

Raysearch Laboratories

SECOND QUARTER (APRIL- JUNE 2024) Order intake SEK 290.3 M (239.2)Net sales SEK 318.9 M (239.5)Operating profit SEK 79.3 M (18.2)Profit after tax SEK 61.4 M (10.9)Earnings per share before/after...

SECOND QUARTER (APRIL- JUNE 2024)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<ul><li>Order intake SEK 290.3 M (239.2)</li><li>Net sales SEK 318.9 M (239.5)</li><li>Operating profit SEK 79.3 M (18.2)</li><li>Profit after tax SEK 61.4 M (10.9)</li><li>Earnings per share before/after dilution SEK 1.79 (0.32)</li><li>Cash flow from operating activities SEK 154.6 M (67.2)</li><li>Order backlog SEK 1,790.5 M (1,954.9) at the end of the period</li></ul>HALF-YEAR (JANUARY- JUNE 2024)<ul><li>Order intake SEK 528.8 M (445.8)</li><li>Net sales SEK 576.1 M (469.6)</li><li>Operating profit SEK 125.1 M (41.9)</li><li>Profit after tax SEK 98.1 M (28.5)</li><li>Earnings per share before/after dilution SEK 2.86 (0.83)</li><li>Cash flow from operating activities SEK 321.9 M (220.9)</li></ul>SIGNIFICANT EVENTS DURING THE SECOND QUARTER<ul><li>Raigmore Hospital in Scotland selects RayCare.</li><li>RaySearch and C-RAD sign collaboration agreement.</li><li>RayCare has been certified to be interoperable with Varian TrueBeam.</li><li>RayStation Used for First-Ever Radiotherapy Treatment with Hitachi's OXRAY system.</li><li>The New York Proton Center expands their RayStation installation.</li></ul>SIGNIFICANT EVENTS AFTER THE END OF THE REPORTING PERIODThere have been no significant events after the end of the reporting period.WEBCASTCEO Johan Löf and Interim CFO Annika Blondeau Henriksson will present RaySearch's interim report for April-June 2024 in a webcast to be held in English on Friday, August 16, 2024, at 10:00 a.m. CEST.Link to webcast: RaySearch Q2, 2024&nbsp;(https://events.teams.microsoft.com/event/c1dbfd69-d879-4fe7-8118-7439e13a91a6@50ba1ecf-6812-4030-81b8-a9b983f4f358)The information contained in this interim report is such that RaySearch Laboratories AB (publ) is obliged to disclose under the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was submitted for publication on August 16, 2024, at 7:45 a.m. CEST.

Stay up to date with our newsletter